WHO urges SA to strengthen capacity to turn research into medicines
Shenaaz El-Halabi says relying on imported medical supplies can leave countries vulnerable.
The World Health Organisation (WHO) has urged South Africa to enhance its capacity to transform scientific research into safe, efficient, and affordable medications. WHO representative Shenaaz El-Halabi emphasized that a robust facility can help bridge the gap between scientific breakthroughs and the production of medicines that can be delivered to patients.
She pointed out that depending on imported medical supplies can leave countries vulnerable during disruptions in global production or increased demand, as seen during the COVID-19 pandemic. El-Halabi made these remarks at the inauguration of the CSIR’s future pharmaceutical facility in Pretoria. According to her, partnerships are crucial for progress.
The World Health Organisation – African region's framework for 2025 and 2035, adopted by African health ministers in 2024, advocates for a comprehensive strategy grounded in these partnerships. El-Halabi noted that governments can align industrial development with public health priorities to achieve this.
Written by urgent.news from SABC News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
